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Purpose. Cardiac output (CO) is a cornerstone parameter in precapillary pulmonary hypertension (PH). The Modelflow (MF)
method offers a reliable noninvasive determination of its beat-by-beat changes. So MF allows exploration of CO adjustment with
the best temporal resolution.Methods. Fifteen subjects (5 PH patients, 10 healthy controls) performed a submaximal supine exercise
on a cycle ergometer after 5min of rest. COwas continuously determined byMF (COMF). Kinetics of heart rate (HR), stroke volume
(SV), and COwere determined with 3monoexponential models. Results. In PH patients, we observed a sudden and transitory drop
of SV upon exercise onset. This implied a transitory drop of CO whose adjustment to a new steady state depended on HR increase.
The kinetics of HR and CO for PH patients was slower than that of controls for all models and for SV in model 1. SV kinetics was
faster for PH patients in models 2 and 3. Conclusion.This is the first description of beat-by-beat cardiovascular adjustments upon
exercise onset in PH.The kinetics of HR and CO appeared slower than those of healthy controls and there was a transitory drop of
CO upon exercise onset in PH due to a sudden drop of SV.
1. Introduction
Precapillary pulmonary hypertension (PH) is a hemody-
namic condition due to increased pulmonary vascular resis-
tances (PVR) leading to progressive right ventricular failure
[1]. It is associated with progressive exercise intolerance as
compared to healthy subjects, due to the inability of the right
ventricle (RV) to cope with increased afterload [1]. This may
also be due to a compression of the left ventricle (LV) by the
dilated RV, thus limiting the expected physiological increase
of stroke volume (SV) at the onset of exercise [2]. Changes
in the adrenergic pathways may be also involved, implying a
tapered contractility and chronotropic response of RV [3]. All
these mechanisms contribute to altering cardiac output (CO)
response to exercise and help understand the prognostic
value of several RV and LV physiological parameters [4–6].
Recommended and developing techniques dedicated to
CO measurement, like thermodilution (TD), allow only
steady-state determination of this parameter [7–9]. Yet, it has
been recently shown that the beat-by-beat and noninvasive
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Table 1: Characteristics of the study population. BMI: body mass
index.
Control subjects PH patients
n 10 5
Age, yrs 24.0 ± 3.2 46.8 ± 8.6
Gender F/M 0/10 3/2
Size, cm 179.1 ± 4.3 169.0 ± 8.8
Weight, kg 76.5 ± 5.6 76.4 ± 20.1
BMI, kg.m−2 23.8 ± 1.1 26.6 ± 6.0
assessment of CO based on the arterial pulse pressure wave
analysis called Modelflow (MF) [10] is a reliable and accurate
procedure in precapillary PH [11] and healthy subjects [12].
Thus, it allows description of the CO adjustment during
metabolic transients with the best possible temporal resolu-
tion. We hypothesized that the beat-by-beat description of
CO kinetics upon exercise onset in precapillary PH would be
slower than those of healthy subjects.
2. Methods
2.1. Study Population. Five patients with precapillary PH
(4 with pulmonary arterial hypertension (PAH) and 1 with
chronic thromboembolic PH (CTEPH) with residual PH
after pulmonary endarterectomy) and 10 healthy control
subjects took part in the experiments (Table 1). All subjects
were preliminarily informed of all procedures and risks
associated with the experimental testing. Informed consent
was obtained from each volunteer, who was aware of the right
of withdrawing from the study at any time without jeopardy.
The study was conducted in accordance with the Declaration
of Helsinki. The protocol was approved by the institutional
ethical committee.
2.2. Right Heart Catheterization (RHC). Invasive hemody-
namic evaluation was carried out in PH patients in a
recumbent position as previously described [11] and included
measures of pulmonary artery mean pressure (mPAP), pul-
monary artery wedge pressure (PAWP), right atrial pressure
(RAP), CO by TD (COTD), PVR calculated as the transpul-
monary gradient (mPAP − PAWP) divided by COTD, and
systemic vascular resistances (SVR) asmean systemic arterial
pressure (MAP) divided by CO determined by MF (COMF),
on the supposition that the RAP can be excluded from its
calculation [13, 14].
2.3. Cardiac Output by Thermodilution and by Modelflow.
COTD and COMF were determined as previously proposed
[11] by injection of 10mL of iced-cold sterile, isotonic glu-
cosaline solution through the proximal catheter’s lumen and
from continuous noninvasive recording of arterial pulse pres-
sure profiles by a Portapres system (TNO-TPD, Amsterdam,
Netherlands), respectively. Mean COMF was calculated as the
mean beat-by-beat value obtained over 1min at steady state,
at rest, and after 2-minute exercise.
2.4. Exercise Hemodynamics. Hemodynamic evaluation was
realized in a recumbent position by means of an electromag-
netically braked cycle ergometer (Cycline 100; Tecmachine,
Andrezieux-Boutheon, France, or Ergoselect 400, Ergoline
GmbH, Bitz, Germany) adapted to the experimental table.
Before exercising, the subjects feet were installed on the ped-
als (raised legs position). A 5min delay was observed before
recording to ensure hemodynamic stabilization at a new
steady state. Then, the patients pedaled at 60 rpm at a work-
load of 20W (PH patients) or 50W (healthy controls) for
5min. COTD was determined in PH patients at rest and dur-
ing the last minute of exercise. Workload was determined in
order to correspond for each group to the samemean propor-
tional increase in the heart rate (HR) reserve. All measures
were obtained at steady HR. The pedaling frequency was
recorded, and its sudden increase at the exercise onset was
used as marker to identify precisely the start of exercise. The
electromechanical characteristics of the ergometer were such
as to permit workload application in less than 50ms.
2.5. Data Treatment. Before the analysis of on-kinetics, the
beat-by-beat HR, SV,MAP, andCO values of all subjects were
time aligned, by setting the time of exercise start as time zero.
As proposed byBringard and coworkers [13], no interpolation
was performed and the analysis was performed on the beat-
by-beat data. Based on previous published findings [2, 15], the
kinetics of SV, CO, andHRwere described with amonoexpo-
nential model firstly proposed by Barstow and Molé [16],
whereby a flow increase with a time delay reflects the circula-
tion time from active muscles to the lungs. The equation was
𝐹(𝑡) = 𝑏 + 𝑎𝜃 (𝑡 − 𝑑) (1 − 𝑒
−(𝑡−𝑑)/𝜏) , (1)
where 𝑡 is time.The parameter 𝑏 represents resting value.The
parameter 𝑎1 is the amplitude of the exponential, and the
parameter 𝜏1 is the time constant. The time 𝑑1 is the time
delay of the exponential.The function 𝜃 is theHeaviside func-
tion (𝜃 (𝑡) = 0 if 𝑡 < 0 and 𝜃 (𝑡) = 1 if 𝑡 ≥ 0). Mean response
time (MRT) is defined by 𝜏1 + 𝑑1.
Since PH patients exhibited a decrease of SV and CO dur-
ing the first 10–20 s after initiation of exercise, two alternative
models, both also based on (1), are proposed for CO and SV
analysis. These 2 alternative models require detection of the
minimumvalue of the studied parameter (SVmin andCOmin),
along with the corresponding time (𝑡SVmin or 𝑡COmin). To
avoid detection of coincidentalminimumdue to the presence
of noise, detection of COmin or SVmin was performed on
smoothed data, using Savitzky and Golay [17] smoothing
filter of the beat-by-beat data. It is noteworthy that smoothed
data are only used for the detection of COmin or SVmin, and
the modelling was performed on the original beat-by-beat
CO and SV data. Specifically, in the second model, after
detection of COmin or SVmin and 𝑡COmin or 𝑡SVmin, the same
model as for model 1 (1) was applied on the beat-by-beat data,
starting from 𝑡min. It is noteworthy thatwhenusing regression
method to fit physiological data like ours, all parameters of
the equation model used interfere together. For instance, in
(1), the time constant (𝜏1) is influenced by the rest data and
parameter 𝑏. Althoughmodel 1 takes into account rest data for
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the fitting, in model 2, by omitting the rest data and starting
from 𝑡min, the beats in the early increase of the kinetics lose
weight in the least square regression compared to beats in
the steady-state region of the curve. Indeed, with COmin and
SVmin being both a single value, compared to the parameter
𝑏 in (1) being computed on several beats, the fitting would
be theoretically less robust when passing through the early
beats after COmin or SVmin, as represented by the residuals.
To cope with this issue, we proposed a third method (model
3), in which the model was forced to pass through COmin or
SVmin data point and the parameters 𝑏 and 𝑑1 of (1) were,
respectively, replaced by COmin or SVmin and 𝑡COmin or 𝑡SVmin.
A graphical representation of the 3models applied onmerged
CO data of the PH patients group is proposed in Figure 1.
The same analysis was performed on the control group. In
order to adapt workloads intensity for each group, resting
and theoretical maximal HR (determined as 220 − age) were
used to calculate, for each patient, HR reserve, considering
the mean resting value as 0% and the theoretical maximal
value as 100%.
2.6. Statistics. The SV, CO, and HR series were fitted by a
weighted nonlinear least squares procedure [18–20] imple-
mented under MATLAB (version 7.13.0.564, MathWorks,
Natick, MA, USA). Initial guesses of the parameters of
the model were entered after visual inspection of the data.
Equation (1) was used as the fittingmodel. In other words, the
estimated model parameters 𝑏, 𝑎1, 𝜏1, and 𝑑1 were obtained
by minimizing the squared difference between the model
function and the experimental data. Constraints were set as
parameters 𝑏, 𝑎1, 𝜏1, and 𝑑1 could not be negative. Time 0
was defined as the instant at which exercise started. In order
to facilitate comparison, time course of HR, SV, and CO was
also determined as relative value, with 0% and 100% being
resting and steady-state exercise values, respectively.
3. Results
The clinical and hemodynamic data at baseline and steady-
state exercise are shown in Tables 1 and 2. The time courses
of HR and SV upon the onset of exercise are shown in
Figure 2 for PH patients and control subjects. For the control
subjects, these parameters increased at exercise onset to reach
a new steady state. For the PH patients, we observe the
same phenomenon for HR but such was not the case for SV.
Here, we observed a sudden drop that lasted for 10 to 20 s
before reaching the baseline level with an increase at steady-
state exercise as compared to resting values. Time courses of
HR, SV, and CO upon exercise onset for PH patients and
control subjects are represented in Figure 3. The mean HR
increase corresponded to 24.3%± 5.1 and 24.6%± 26.0 of the
theoretical HR reserve for healthy controls and PH patients,
respectively. At the onset of exercise, CO increased for the
control group to reach a new steady state. For the PHpatients,
CO decreased over 3 to 5 beats where it stabilized during
20 s before increasing and reaching a new steady level, higher
than its resting value. The time course of SVR upon exercise














































Figure 1: Graphical representation of the 3models used for CO data
analysis. CO, cardiac output; time 0 (black dotted line) corresponds
to exercise onset; the red line in panels (a), (b), and (c) corresponds
to the 3 models description; the green point in panels (b) and (c)
corresponds to the minimal CO output (COmin) determined for
models 2 and 3, respectively. CO data of the PH patients were
temporally aligned and superimposed. Analysis was performed
individually for all subjects.
observed a sudden drop at the onset of exercise but these
changes were not visible for the PH patients.
The characteristic parameters describing the HR, SV, and
CO kinetics according to the 3 theoretical models upon exer-
cise onset are presented in Table 3. For each parameter, we
observed a steady-state value higher than that of baseline
(rest) with the 3 different models, except for SV assessed
by method 1 in the PH patients where SV remained stable
between baseline (90.6 ± 32.1mL) and steady state (97.6 ±
38.8mL). MRT for HR and CO was longer in PH patients as
compared to control subjects regardless of the model used.
For SV, the overall kinetics assessed by model 1 was clearly
slower in PHpatients, as evidenced by aMRTof 133.5±13.7 s,
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Figure 2: Time course of beat-by-beat heart rate (HR) and stroke volume (SV) upon exercise onset. Time 0 corresponds to exercise start.
Data were temporally aligned and superimposed for both groups.
Table 2: Baseline and steady-state exercise hemodynamics of the study population. RAP, right atrial pressure; mPAP, pulmonary artery
mean pressure; PAWP, pulmonary artery wedge pressure; MAP, mean systemic pressure; SpO2, arterial oxygen saturation by pulsoxymetry;
COTD, cardiac output determined by thermodilution; COMF, cardiac output determined by Modelflow; SVMF, stroke volume determined by
Modelflow; HRMF, heart rate determined by Modelflow; PVR, pulmonary vascular resistances; SVR: systemic vascular resistances.
Baseline (rest) Effort (steady state)
Patients (𝑛 = 5) Controls (𝑛 = 10) Patients (𝑛 = 5) Controls (𝑛 = 10)
RAP, mmHg 5.4 ± 3.2 — — —
mPAP, mmHg 38.8 ± 12.0 — 50.2 ± 19.4 —
PAWP, mmHg 9.4 ± 2.4 — 16.6 ± 9.3 —
MAP, mmHg 86.9 ± 1.2 72.5 ± 1.8 96.8 ± 1.1 76.3 ± 0.8
SpO2, % 95.4 ± 3.3 97.2 ± 0.6 95.0 ± 4.3 97.4 ± 0.7
COTD, l⋅min−1 6.3 ± 3.0 — 7.2 ± 2.4 —
COMF, l⋅min−1 8.4 ± 0.1 6.4 ± 0.3 9.5 ± 0.2 10.3 ± 0.2
SVMF, ml 94.8 ± 1.9 99.1 ± 2.7 95.3 ± 1.4 110.7 ± 1.7
HRMF, min
−1 89.8 ± 1.1 64.8 ± 2.9 106.1 ± 0.9 92.9 ± 1.1
PVR, WU 5.7 ± 4.0 — 5.4 ± 3.7 —
SVR, WU 10.4 ± 0.2 11.4 ± 0.7 10.2 ± 0.2 7.4 ± 0.2
much longer than that of control subjects (20.2±13.4 s). Here,
model 1 provided inaccurate kinetics description, due to its
inability to detect sudden drop of SV at the onset of exercise.
Models 2 and 3, considering analysis upon minimal SV
detection, revealed faster kinetics for SV in PH patients than
in control subjects. SVAnalysis withmodel 2was not possible
for 2 control subjects, due to the inability of the model to
detect SVmin, providing aberrant kinetics characteristics.
4. Discussion
In this pilot study, we described for the first time the beat-
by-beat kinetics of CO at exercise onset in PH patients. The
overall kinetics of cardiovascular adjustment in response to
supine exercise appeared to be slower in PH patients than
in control subjects, in agreement with the tested hypothesis.
Moreover, there was a decrease in CO at the onset of exercise
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Table 3: Parameters describing the heart rate (HR), stroke volume (SV), and cardiac output (CO) kinetics upon exercise onset for PH patients
(𝑛 = 5) and control subjects (𝑛 = 10). 𝑏, baseline mean value as determined by model 1; min, minimal value detected by models 2 and 3; 𝐴1,
amplitude of the parameter increase; 𝜏1, time constant; 𝑑1, time delay of the exponential; 𝑡min, time of minimal value determined for models 2
and 3; MRT, mean response time; ss, steady-state exercise mean value as determined by the model. ∗Analysis with model 2 was possible only
for 8 control subjects.
PH (𝑛 = 5)
𝑏 or min 𝐴1 𝜏1 (s) 𝑑1 or 𝑡min (s) MRT (s) ss
HR (min−1)
Model 1 87.7 ± 14.5 20.0 ± 15.9 39.3 ± 24.2 −2.3 ± 12.2 37.1 ± 27.7 106.4 ± 23.5
Model 2 91.9 ± 18.4 16.1 ± 10.6 50.3 ± 39.0 12.7 ± 11.2 63.0 ± 30.2 106.4 ± 23.5
Model 3 88.6 ± 15.7 18.6 ± 13.0 194.2 ± 336.4 10.6 ± 12.0 204.8 ± 347.9 106.5 ± 23.5
SV (ml)
Model 1 90.6 ± 32.1 48.3 ± 89.2 372.8 ± 787.7 60.4 ± 83.1 433.2 ± 868.7 97.6 ± 38.8
Model 2 80.0 ± 34.1 17.2 ± 215 13.4 ± 17.4 13.8 ± 7.3 27.2 ± 24.7 97.7 ± 38.7
Model 3 76.2 ± 32.5 20.6 ± 24.7 10.4 ± 12.6 12.5 ± 8.5 22.9 ± 20.8 97.7 ± 38.7
CO (l⋅min−1)
Model 1 8.1 ± 3.1 1.9 ± 1.2 88.3 ± 79.0 45.2 ± 65.2 133.5 ± 130.7 9.8 ± 2.5
Model 2 7.5 ± 3.2 2.2 ± 1.7 42.7 ± 38.2 11.9 ± 9.5 54.7 ± 38.2 9.8 ± 2.5
Model 3 7.0 ± 3.2 2.7 ± 1.9 27.2 ± 22.4 10.8 ± 10.3 38.0 ± 23.5 9.8 ± 2.5
Controls (𝑛 = 10)
𝑏 or min 𝐴1 𝜏1 (s) 𝑑1 or 𝑡min (s) MRT (s) ss
HR (min−1)
Model 1 60.7 ± 11.1 32.3 ± 8.6 16.2 ± 6.9 −7.4 ± 3.1 8.8 ± 7.3 93.7 ± 8.2
Model 2∗ 76.6 ± 11.0 17.0 ± 3.7 44.2 ± 86.0 7.9 ± 10.1 52.1 ± 92.8 93.2 ± 9.0
Model 3 74.2 ± 12.2 19.0 ± 6.7 19.4 ± 14.7 3.9 ± 7.1 23.3 ± 21.7 93.7 ± 8.2
SV (ml)
Model 1 98.5 ± 17.1 16.5 ± 6.8 68.3 ± 82.6 5.7 ± 10.6 73.9 ± 84.8 113.3 ± 17.7
Model 2∗ 98.8 ± 19.1 13.5 ± 3.8 22.3 ± 18.2 16.4 ± 21.5 38.7 ± 28.8 112.3 ± 19.8
Model 3 94.0 ± 17.6 18.8 ± 6.5 32.6 ± 28.4 3.9 ± 6.2 36.5 ± 28.2 113.3 ± 17.7
CO (l⋅min−1)
Model 1 6.0 ± 1.5 4.4 ± 1.5 26.3 ± 12.7 −6.2 ± 3.9 20.2 ± 13.4 10.6 ± 2.1
Model 2∗ 7.7 ± 2.5 2.8 ± 0.9 30.2 ± 22.0 9.0 ± 17.7 39.2 ± 27.6 10.5 ± 2.3
Model 3 7.4 ± 2.2 3.1 ± 0.8 31.9 ± 18.8 1.1 ± 0.8 32.9 ± 18.6 10.6 ± 2.1
that was due to a transitory drop in SV. It is noteworthy that
this pattern of response to exercise was recorded in all the
5 PH patients under study. Moreover, our results suggest
that there was no significant increase of SV during exercise
and that virtually all the CO increase in response to exercise
could be attributed to the HR changes. On the other hand,
we observed that the HR kinetics was slower in PH patients
than that of healthy controls, whatever themodel used for the
data analysis. In fact, HR response was not only limited in
its amplitude, as previously demonstrated [3] (the so-called
impaired chronotropic response in PAH) but also in its kine-
tics, which was systematically slower than that of healthy
subjects. This is in line with previously published work that
demonstrated a close relationship between HR and mPAP in
exercising patients with severe precapillary PH [21].The close
relationship between CO response and kinetics of oxygen
uptake (VO2) upon exercise onset in healthy subjects [2, 14,
22–25] and in heart failure [26, 27] is also well known. It was
also suggested in pulmonary vascular diseases [28, 29]. In
agreement with the present results, reported VO2 kinetics is
blunted in this group of patients. With kinetics of VO2 being
reported and currently accepted to be described as an expo-
nential [30–33], any changewould be best detected at exercise
onset. To the best of our knowledge, however, no study
described or indirectly suggested a transitory decrease of CO
at the early onset of exercise in these conditions. This may
be related to the lower sampling frequency during the initial
cardiodynamic phase, limited by breathing pattern. Indeed,
the higher frequency of cardiovascular variables assessed on
a beat-by-beat basis together with their inherent excellent
signal-to-noise ratio compared to pulmonary VO2 allows
robust kinetics analysis and may have permitted the present
findings.
4.1. About SV Kinetics. It is possible that the sudden increases
in venous return may have induced, at least transiently, an
increase in the RV end-diastolic volume and have worsened
the RV dysfunction at the onset of exercise. Accordingly, a
transitory fall of LV preload associated with an exaggerated
compression of the LV by the RVwill lead to a global decrease
of LV end-diastolic volume and transient drop in SV that is
not counterbalanced by the HR increases.The resulting effect
is a sudden drop in CO. It may also be that the transitory
decreased SV may be an additional marker of hemodynamic
transitional RV inability to accept an additional burden of
venous return and, therefore, consequently, a marker of poor
outcome. This could be the case, considering the severity of
the hemodynamic impairment of the PH patients included in
this study. Alternatively, it is also possible that dysfunctional
RV, at the onset of exercise, becomes unable to cope with an
increased afterload (mPAP).This, together with a retarded or
inoperative inotropic effect (in response to increased after-
load), may have led to the observed transitory SV reduction.
It is also noteworthy that SV kinetics determined bymodels 2


































Figure 3: Time course of beat-by-beat heart rate (HR), stroke
volume (SV), and cardiac output (CO) upon the onset of exercise.
Data are superimposed for all PH patients (black, 𝑛 = 5) and control
subjects (grey, 𝑛 = 10) and represented as relative values from 0
(baseline) to 100% (steady-state exercise). Time 0 corresponds to
exercise start. Data were temporally aligned and superimposed for
both groups.
and 3 were faster for PH patients than that of control subjects.
This is also an argument toward a decreased volume reserve
in PH and a new steady volume attained earlier.
4.2. About Exercise and PH. Exercise hemodynamics is
becoming of primary importance in the evaluation of pulmo-
nary vascular diseases. In fact, it has been well demonstrated
to better describe the real resistive properties of pulmonary
vascular bed [34, 35]. Thereby, it may be a decisive help for
revealing pulmonary vascular disease undetected by resting
measurements [36–40], assessing PAH severity or driving its
therapeutic approach [41]. As suggested in the present study,
exercise exploration could provide new information on the
mechanisms of cardiodynamic adjustments in diseases. It
may also help unmasking postcapillary PH that may occur
in patients with heart failure with preserved ejection fraction
[42]. Moreover, recently published studies proposed new
criteria for diagnosis of exercise pulmonary hypertension [36,
37] or demonstrated prognostic role of exercise hemodynam-
ics [43], reinforcing the interest of hemodynamic exploration
during exercise. As recommended by current guidelines
[44], rehabilitation programs are now part of the standard
care for PH patients. Here, availability of inexpensive and
reliable noninvasive CO monitoring may be desirable and
help distinguish the hemodynamic determinants of exercise
intolerance in PH patients.
4.3. Limitations of the Present Study. This study has several
limitations. First, the small number of included patients may
imply that our results are only applicable to the studied
patients, with the need to confirm our findings in larger
populations. However, the individual kinetics analysis char-
acteristics showed a similar pattern for all the 5 PH patients,
strengthening the results obtained. Moreover, the cardio-
vascular responses upon exercise onset of the healthy con-
trol group were consistent with the expected physiological
response to metabolic changes, making it very unlikely that
the observed phenomenon could be due to an artifact.
Second, it may be that the slower kinetics could have been
explained by a lower workload. In fact, this is unlikely as
previous physiological study showed that the cardiovascular
response is generally faster for lower workload [2] and more-
over as the different workload corresponded to similar HR
increase in proportion to theoretical HR reserve. Third, the
baseline and steady-state CO measurements by thermodilu-
tion (COTD) and uncorrectedMF [12] (COMF) in PH patients
showed differences that might have consequences on data
interpretation and confirmed that MF is not accurate in
determining absolute CO values without calibration against a
reference method [12, 44]. In fact, a correction factor was not
imposed to theMF data because we aimed at analyzing kinet-
ics. Under these circumstances, MF has shown to be precise
and accurate enoughwithout such a procedure. Nevertheless,
the calculated correction factor would have been similar to
those previously published for the MF technology [11, 12, 14].
Fourth, characteristics of control subjects differed from the
PH patients in several aspects that may have influenced the
results. For example, it was shown that kinetics of VO2 is
slowed as a function of age. However, the kinetics blunting
in the included PH patients exceeded by far what could have
been expected from normal ageing [45, 46]. Finally, it is
likely that results could be different when obtained in upright
positionwhere the cardiovascular adjustments were shown to
differ from supine position in healthy humans. Nevertheless,
RHC is performed in the supine position, so the present study
corresponds to the actual clinical setting of hemodynamic
evaluation in the catheterization laboratory.
5. Conclusions
To our knowledge, this is the first description of beat-by-beat
cardiovascular adjustments upon exercise onset in patients
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Figure 4: Time course of systemic vascular resistances (SVR) upon exercise onset. Time 0 corresponds to exercise start. Data were temporally
aligned and superimposed for both groups.
with severe precapillary PH.The overall kinetics parameter of
HR, SV, and CO appeared slower in PH patients than that in
healthy controls.Moreover, we documented a transitory drop
in cardiac output upon exercise onset due to a sudden SV
reduction, with the CO adaptation to the increasedmetabolic
demand being assumed by HR increases. A larger study is
warranted in order to confirm these results and explore their
clinical signification.
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